OSI PHARMACEUTICALS, INC.

Inactive Instrument

OSI Pharmaceuticals, Inc. Stock

Stocks

US6710401034

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

Press Releases: OSI Pharmaceuticals, Inc.

09/06/10	OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals	PR
08/06/10	OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI	PR
04/06/10	OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes	BU
03/06/10	OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period	PR
17/05/10	OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010	PR

More press releases

News in other languages: OSI Pharmaceuticals, Inc.

17/05/10

OSI PHARM : a reçu une offre de rachat du japonais Astellas

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	WUXI APPTEC CO., LTD.	-4.83%	+2.88%	+55.87%	+69.12%	69.4B
	ARGENX SE	+0.02%	+1.42%	+12.77%	+75.21%	57.24B
	LONZA GROUP AG	-1.34%	+3.53%	+23.22%	+101.58%	57.62B
	IQVIA HOLDINGS INC.	+2.62%	-1.17%	+29.37%	+37.84%	43.65B
	BEONE MEDICINES AG	+5.09%	+9.53%	+26.62%	+121.44%	44.03B
	REVOLUTION MEDICINES, INC.	+8.24%	+1.06%	+224.03%	+767.69%	38.08B
	CELLTRION, INC.	-1.86%	+11.46%	+26.67%	+61.40%	36.31B
	GENMAB A/S	-2.97%	-6.89%	+91.79%	+74.60%	32.61B
	WUXI BIOLOGICS (CAYMAN) INC.	-2.18%	+5.68%	+36.21%	-0.69%	25.47B
	Average	+0.31%	+2.24%	+58.51%	+145.36%	44.93B
	Weighted average by Cap.	+0.05%	+2.44%	+53.94%	+138.05%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!